Free Trial
NYSE:EVH

Evolent Health Q3 2026 Earnings Date & Estimates

Evolent Health logo
$4.56 -0.32 (-6.47%)
Closing price 10/16/2026 03:59 PM Eastern
Extended Trading
$4.58 +0.03 (+0.57%)
As of 10/16/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Evolent Health is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, before market opens. The conference call is scheduled for 8:30 AM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:30 AM ET

What Analysts Expect from Evolent Health in Q3 2026

Evolent Health is expected to post earnings of $0.06 per share on revenue of $727.06 million. In the same quarter a year earlier Evolent Health reported $0.05 per share on revenue of $479.53 million. Evolent Health last reported on August 6, 2026, posting $0.02 per share and beating the -$0.0104 consensus estimate. Evolent Health has beaten the consensus EPS estimate in 3 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.06
Expected Revenue
$727.06 million
Prior-Year EPS
$0.05
Prior-Year Revenue
$479.53 million
Expected EPS Growth
+20.0%
Expected Revenue Growth
+51.6%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.02 (Beat by +$0.0304)
Last Quarter Revenue
$484.50 million
EPS Beat Rate
3 of last 8 quarters

Evolent Health Q3 2026 Earnings FAQ

Evolent Health (NYSE:EVH) is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Evolent Health's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Evolent Health to post earnings of $0.06 per share for Q3 2026.

The consensus revenue estimate for Evolent Health is $727.06 million for Q3 2026.

Evolent Health Earnings Headlines

ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
See More Evolent Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Evolent Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Evolent Health and other key companies, straight to your email.

About Evolent Health

Evolent Health (NYSE:EVH). is a healthcare services and technology company that helps health plans and providers manage specialty care and transition to value-based models. Its offerings are designed to coordinate care, improve clinical outcomes and support more predictable healthcare costs across complex medical conditions.

The company provides technology-enabled administrative, clinical and analytical services for areas such as oncology, cardiology, musculoskeletal care and other specialty-care categories. Its platform and services may include provider and patient engagement, care management, utilization management, payment and claims support, data analytics, and clinical decision-making tools.

Evolent primarily serves health plans, employers, providers and other healthcare organizations in the United States. The company was founded in 2011 and became a publicly traded company in 2015. Evolent is headquartered in Arlington, Virginia, and has been led by co-founder Seth Blackley, who has served as chief executive officer.

View Evolent Health Profile